Watchlist for March 23, 2007

See one of the recent 'Chart Reading' posts for some potential swing candidates.

Potential day trades:

(From Briefing.com)

Gapping Down

Gapping down on weak earnings/guidance: CECE -13.9%, JBL -9.8% (also downgraded at BMO), SRSL -7.3%, NKE -2.4%, PALM -1.9%... Other news: HNAB -24.2% (provides pipeline update, co no longer pursuing Special Protocol Assessment with FDA for Marqibo), AMGN -3.4% and DNA -2.2% (AMGN halts PACCE trial due to poor survival in patients that used Vectibix along with DNA's Avastin and chemotherapy to treat colorectal cancer; DNA also reaffirms), TWW -3.6% (prices 11 mln share offering at $8/share), BEAV -3.1% (prices 10.5 mln share offer at $32/share), AGP -3.0% (prices $240 mln in convertible senior notes), RRI -2.6% (downgraded to Sell at BofA), RACK -2.4% (profit-taking after yesterday's takeover rumor-fueled move), STP -2.4% (downgraded to Neutral at Goldman), BKHM -2.1% (announces private placement).

Gapping Up

Gapping up on strong earnings/guidance: COMS +3.4%... M&A: PXR +22.8% (to be acquired by AVY for $30.50/share), OPWV +5.6% (guides Q3 below consensus, announces it will explore strategic alternatives), DCX +4.0% (Daimler shares jump on speculation of Chrysler sale - Bloomberg.com)... Other news: IMCL +23.6% (AMGN halts PACCE trial for Vectibix, which was rival to IMCL's Erbitux; also two broker upgrades), HOKU +12.8% (signs 99-year ground lease in Pocatello, Idaho), AGIX +9.4% (short-covering continues ahead of presentation next week), ASTI +6.3% (SC-13D filing out today with details on previously-announced Norsk Hydro investment; also continued momentum in solar plays), DNDN +4.8%, URBN +4.1% and CWTR 3.4% (Goldman recommends stocks), PICO +3.7% (Cramer positive on stock), DSTI +3.4% (continued momentum in solar stocks), HLF +3.3% (co and AEG announce a 5-yearr multi-mln dollar expansion), Q +3.1% (Cramer says co could win a $20 bln govt contract), ADLS +1.6% (profiled in BusinessWeek Online).

Disclaimer & How I use this list